arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Omada Health, Inc.

OMDA

$23.67 ▲ +3.34 (+16.43%) at close

4 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bearish

auto_awesome

Analytical Summary

Omada Health, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $867.2M

Dividend Yield —

Revenue Growth 53.2% ↗

Op. Margin -4.6% ↗

ROIC -5.2% ↘

FCF / Share $0.46 ↗

Trailing P/E —

Price / Book 6.0x

FCF Yield 2.0%

Debt / Equity 0.00

info Valuation on last close. End-of-day price, Aug 7, 2026.

4-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$260.21M

↑ +53.2% —

Net Income Profit after all expenses

$-12.78M

↑ +72.9% —

Operating Margin Operating profit as % of sales

-4.6%

↑ +82.1% 20th

FCF / Share Free cash flow per share

$0.46

↑ +110.3% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	53.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+566%)	38.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+379%)	—	—
EPS Growth YoY (%)	94.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	35.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	72.9% Excellent Excellent Year-over-year change in net income	30.2% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	36.3% Excellent Excellent Year-over-year change in free cash flow	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	-4.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-131%)	-25.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-271%)	-53.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-458%)	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-4.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-141%)	-27.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-331%)	-55.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-558%)	—
FCF Margin (%) (%)	6.5% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	-20.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-40.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-1.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	-5.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.3% Good Good Return earned on debt + equity capital invested Optimal: > 10%	18.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-3.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-28.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	12.3% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	19.3% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+29%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Debt to Equity (x)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	-0.08x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-113%)	—	—
Interest Coverage (x)	-4.95x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	-16.12x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-222.04M	$-46.62M	—	—
Debt / EBITDA (x)	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.77x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$7.10	$21.99	$17.32	—
Basic EPS, GAAP (USD)	$-0.35	$-6.11	$-9.52	—
Free Cash Flow per Share (USD)	$0.46	$-4.50	$-7.07	—
Book Value per Share (USD)	$3.93	$-47.13	$-49.37	—
Tangible Book Value per Share (USD)	$3.66	$-49.27	$-49.37	—
Basic Weighted Avg Shares (shares)	36.64M	7.72M	7.09M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$197.21M	$59.11M	—	—
LT Debt (USD)	$0.00	$29.77M	—	—
Total Equity (USD)	$229.68M	$-384.40M	$-350.11M	$-293.17M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$260.21M	$169.80M	$122.78M	—
Depreciation Expense (USD)	$5.49M	$4.80M	$4.45M	—
Net Income, GAAP (USD)	$-12.78M	$-47.14M	$-67.51M	—
Operating Cash Flow (USD)	$18.25M	$-34.18M	$-49.74M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 11 quarters

Omada Health, Inc.

Analytical Summary

4-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare OMDA with peers